Work

Supplementary Figures 1-4 from CD44 Attenuates Activation of the Hippo Signaling Pathway and Is a Prime Therapeutic Target for Glioblastoma

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figures 1-4 from CD44 Attenuates Activation of the Hippo Signaling Pathway and Is a Prime Therapeutic Target for Glioblastoma

DOI: 10.1158/0008-5472.22386800.v1

Authors: Yin Xu, Ivan Stamenkovic, Qin Yu

Language: English

Topic: Hippo pathway signaling and YAP/TAZ

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362416881

Cites:

Cited by:

Related to: 10